The MA-ncRNAs Axis in Diabetes Complications: Novel Mechanism and Therapeutic Potential
Overview
Affiliations
Diabetes, a multifaceted metabolic disorder, poses a significant global health burden with its increasing prevalence and associated complications, such as diabetic nephropathy, diabetic retinopathy, diabetic cardiomyopathy, and diabetic angiopathy. Recent studies have highlighted the intricate interplay between N-methyladenosine (mA) and non-coding RNAs (ncRNAs) in key pathways implicated in these diabetes complications, like cell apoptosis, oxidative stress, and inflammation. Thus, understanding the mechanistic insights into how mA dysregulation impacts the expression and function of ncRNAs opens new avenues for therapeutic interventions targeting the mA-ncRNAs axis in diabetes complications. This review explores the regulatory roles of mA modifications and ncRNAs, and stresses the role of the mA-ncRNA axis in diabetes complications, providing a therapeutic potential for these diseases.